Outlook Therapeutics, Inc. - Common Stock (NQ: OTLK )
1.695
-0.015
(-0.88%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 19, 2025
Add to My Watchlist
All News about Outlook Therapeutics, Inc. - Common Stock



Analyst Expectations for Outlook Therapeutics's Future
April 03, 2023
Via Benzinga
Earnings Outlook For Outlook Therapeutics
December 26, 2022
Via Benzinga




Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
February 06, 2023
Via Benzinga




12 Health Care Stocks Moving In Tuesday's After-Market Session
November 15, 2022
Via Benzinga


Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via Benzinga




Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
Via Benzinga

Via Benzinga




Via Benzinga



Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free